Differential intracellular compartmentalization of herpetic thymidine kinases (TKs) in TK gene-transfected tumor cells: Molecular characterization of the nuclear localization signal of herpes simplex virus type 1 TK

Journal of Virology

Volumn 72, Issue 12, 1998, Pages 9535-9543

  Degrève, Bart ^a,b   Johansson, Magnus ^b   De Clercq, Erik ^a   Karlsson, Anna ^b   Balzarini, Jan ^a  

^a REGA INSTITUTE FOR MEDICAL RESEARCH   (Belgium)

^b KAROLINSKA INSTITUTE   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID; ARGININE; GREEN FLUORESCENT PROTEIN; HISTIDINE; HYBRID PROTEIN; MUTANT PROTEIN; NONAPEPTIDE; THYMIDINE KINASE;

ARTICLE; CELL NUCLEUS; CONTROLLED STUDY; CYTOSOL; ENZYME LOCALIZATION; GENETIC TRANSFECTION; HERPES SIMPLEX VIRUS 1; HERPES SIMPLEX VIRUS 2; HUMAN; HUMAN CELL; OSTEOSARCOMA CELL; PRIORITY JOURNAL; SITE DIRECTED MUTAGENESIS; VARICELLA ZOSTER VIRUS;

EID: 0031743365     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/jvi.72.12.9535-9543.1998     Document Type: Article

References (48)

1. Adachi, N., M. Miyaike, S. Kato, R. Kanamaru, H. Koyama, and A. Kikuchi. 1997. Cellular distribution of mammalian DNA topoisomerase II is determined by its catalytically dispensable C-terminal domain. Nucleic Acids Res. 25:3135-3142.
2. Andrei, G., R. Snoeck, P. Goubau, J. Desmyter, and E. De Clercq. 1992. Comparative activity of various compounds against clinical strains of herpes simplex virus. Eur. J. Clin. Microbiol. Infect. Dis. 11:143-151.
3. Arnér, E. S. J., and S. Eriksson. 1995. Mammalian deoxyribonucleoside kinases. Pharmacol. Ther. 67:155-186.
4. Balasubramaniam, N. K., V. Veerisetty, and G. A. Gentry. 1990. Herpesviral deoxythymidine kinases contain a site analogous to the phosphoryl-binding arginine-rich region of porcine adenylate kinase: comparison of secondary structure predictions and conservation. J. Gen. Virol. 71:2979-2987.
5. Balzarini, J., E. De Clercq, D. Ayusawa, and T. Seno. 1985. Murine mammary FM3A carcinoma cells transformed with the herpes simplex virus type 1 thymidine kinase gene are highly sensitive to the growth-inhibitory properties of (E)-5-(2-bromovinyl)-2′-deoxyuridine and related compounds. FEBS Lett. 185:95-100.
6. Balzarini, J., E. De Clercq, A. Verbruggen, D. Ayusawa, K. Shimizu, and T. Seno. 1987. Thymidylate synthase Is the principal target enzyme for the cytostatic activity of (E)-5-(2-bromovinyl)-2′-deoxyuridine against murine mammary carcinoma (FM3A) cells transformed with the herpes simplex virus type 1 and type 2 thymidine kinase gene. Mol. Pharmacol. 32:410-416.
7. Balzarini, J., C. Bohman, and E. De Clercq. 1993. Differential mechanism of cytostatic effect of (E)-5-(2-bromovinyl)-2′-deoxyuridine, 9-(1,3-dihydroxy-2-propoxymethyl)guanine, and other antiherpetic drugs on tumor cells transfected by the thymidine kinase gene of herpes simplex virus type 1 or type 2. J. Biol. Chem. 268:6332-6337.
8. Balzarini, J., C. Bohman, R. T. Walker, and E. De Clercq. 1994. Comparative cytostatic activity of different antiherpetic drugs against herpes simplex virus thymidine kinase gene-transfected tumor cells. Mol. Pharmacol. 45:1253-1258.
9. Balzarini, J., K. W. Morin, E. E. Knaus, L. I. Wiebe, and E. De Clercq. 1995. Novel (E)-5-(2-iodovinyl)-2′-deoxyuridine derivatives as potential cytostatic agents against herpes simplex virus thymidine kinase gene transfected tumors. Gene Ther. 2:317-322.
10. Brown, D. G., R. Visse, G. Sandhu, A. Davies, P. J. Rizkallah, C. Melitz, W. C. Summers, and M. R. Sanderson. 1995. Crystal structures of the thymidine kinase from herpes simplex virus type-I in complex with deoxythymidine and ganciclovir. Nat. Struct. Biol. 2:876-881.
11. Chalfie, M., Y. Tu, G. Euskirchen, W. W. Ward, and D. C. Prasher. 1994. Green fluorescent protein as a marker for gene expression. Science 263:802-805.
12. Chelsky, D., R. Ralph, and G. Jonak. 1989. Sequence requirements for synthetic peptide-mediated translocalization to the nucleus. Mol. Cell. Biol. 9:2487-2492.
13. Chen, S.-H., W. J. Cook, K. L. Grove, and D. M. Coen. 1998. Human thymidine kinase can functionally replace herpes simplex virus type 1 thymidine kinase for viral replication in mouse sensory ganglia and reactivation from latency upon explant. J. Virol. 72:6710-6715.
14. - cells by herpes simplex virus type I and type II. II. Purification and characterization. J. Biol. Chem. 251:2605-2610.
15. Coen, D. M., M. Kosz-Vnenchak, J. G. Jacobson, D. A. Leib, C. L. Bogard, P. A. Schaffer, K. L. Tyler, and D. M. Knipe. 1989. Thymidine kinase-negative herpes simplex virus mutants establish latency in mouse trigeminal ganglia but do not reactivate. Proc. Natl. Acad. Sci. USA 86:4736-4740.
16. Culver, K. W., J. Van Gilder, C. J. Link, T. Carlstrom, T. Buroker, W. Yuh, K. Koch, K. Schabold, S. Doornbas, and B. Wetjen. 1994. Gene therapy for the treatment of malignant brain tumors with in vivo tumor transduction with the herpes simplex thymidine kinase gene/ganciclovir system. Hum. Gene Ther. 5:343-379.
17. De Clercq, E. 1993. Antivirals for the treatment of herpesvirus infections. J. Antimicrob. Chemother. 32:121-132.
18. Degrève, B., G. Andrei, M. Izquierdo, J. Piette, K. Morin, E. E. Knaus, L. I. Wiebe, I. Basrah, R. T. Walker, E. De Clercq, and J. Balzarini. 1997. Varicella-zoster virus thymidine kinase gene and antiherpetic pyrimidine nucleoside analogues in a combined gene/chemotherapy treatment for cancer. Gene Ther. 4:1107-1114.
19. Dingwall, C., and R. A. Laskey. 1991. Nuclear targeting sequences - a consensus? Trends Biochem. Sci. 16:478-481.
20. Efstathiou, S., S. Kemp, G. Darby, and A. C. Minson. 1989. The role of herpes simplex virus type 1 thymidine kinase in pathogenesis. J. Gen. Virol. 70:869-879.
21. Fejes-Toth, G., D. Pearce, and A. Naray-Fejes-Toth. 1998. Subcellular localization of mineralocorticoid receptors in living cells: effects of receptor agonists and antagonists. Proc. Natl. Acad. Sci. USA 95:2973-2978.
22. Freeman, S. M., C. McCune, W. Robinson, C. N. Abboud, G. N. Abraham, C. Angel, and A. Marrogi. 1995. The treatment of ovarian cancer with a gene modified cancer vaccine: a phase I study. Hum. Gene Ther. 6:927-939.
23. Garcia-Bustos, J., J. Heitman, and M. N. Hall. 1991. Nuclear protein localization. Biochim. Biophys. Acta 1071:83-101.
24. Georget, V., J. M. Lobaccaro, B. Terouanne, P. Mangeat, J. C. Nicolas, and C. Sultan. 1997. Trafficking of the androgen receptor in living cells with fused green fluorescent protein-androgen receptor. Mol. Cell. Endocrinol. 129:17-26.
25. Goldfarb, D. S., J. Gariepy, G. Schoolnik, and R. D. Kornberg. 1986. Synthetic peptides as nuclear localization signals. Nature 332:641-644.
26. Haarr, L., and T. Flatmark. 1987. Evidence that deletion of coding sequences in the 5′ end of the thymidine kinase gene of herpes simplex virus type 1 affects the stability of the gene products. J. Gen. Virol. 68:2817-2829.
27. He, Q., S. Skog, N. Wang, S. Eriksson, and B. Tribukait. 1996. Characterization of a peptide antibody against a C-terminal part of human and mouse cytosolic thymidine kinase, which is a marker for cell proliferation. Eur. J. Cell. Biol. 70:117-124.
28. Johansson, M., and A. Karlsson. 1996. Cloning and expression of human deoxyguanosine kinase cDNA. Proc. Natl. Acad. Sci. USA 93:7258-7262.
29. Johansson, M., and A. Karlsson. 1997. Cloning of the cDNA and chromosome localization of the gene for human thymidine kinase 2. J. Biol. Chem. 272:8454-8458.
30. Johansson, M., S. Brismar, and A. Karlsson. 1997. Human deoxycytidine kinase is localized in the cell nucleus. Proc. Natl. Acad. Sci. USA 94:11941-11945.
31. Kalderon, D., B. L. Roberts, W. D. Richardson, and A. E. Smith. 1984. A short amino acid sequence able to specify nuclear localization. Cell 39:499-509.
32. Kanda, T., K. F. Sullivan, and G. M. Wahl. 1998. Histone-GFP fusion protein enables sensitive analysis of chromosome dynamics in living mammalian cells. Curr. Biol. 8:377-385.
33. Kun, L. E., A. Gajjar, M. Muhlbauer, R. L. Heideman, R. Sanford, M. Brenner, A. Walter, J. Langston, J. Jenkins, and S. Facchini. 1995. Stereotactic injection of herpes simplex thymidine kinase vector producer cells (PA317-G1Tk1SvNa.7) and intravenous ganciclovir for the treatment of progressive or recurrent primary supratentorial pediatric malignant brain tumors. Hum. Gene Ther. 6:1231-1255.
34. Lanford, R. E., and J. S. Butel. 1984. Construction and characterization of an SV40 mutant defective in nuclear transport of T antigen. Cell 37:801-813.
35. Lee, C. G., C. G. Kim, R. Namkung, S. E. Lee, and S. D. Park. 1990. Transfection of mouse cells with thymidine kinase gene of herpes simplex virus. Cytotechnology 3:141-147.
36. Levy, J. P., R. R. Muldoon, S. Zolotukhin, and C. J. Link. 1996. Retroviral transfer and expression of a humanized, red-shifted green fluorescent protein gene into human tumor cells. Nat. Biotechnol. 14:610-614.
37. Morin, N., C. Delsert, and D. F. Klessig. 1989. Nuclear localization of the adenovirus DNA-binding protein: requirement for two signals and complementation during viral infection. Mol. Cell. Biol. 9:4372-4380.
38. Oldfield, E. H. 1993. Gene therapy for the treatment of brain tumors using intra-tumoral transduction with the thymidine kinase gene and intravenous ganciclovir. Clinical Protocols. Hum. Gene Ther. 4:36-69.
39. Raffel, C., K. Culver, D. Kohn, M. Nelson, S. Siegel, F. Gillis, C. J. Link, and J. G. Villablanca. 1994. Gene therapy for the treatment of recurrent pediatric malignant astrocytomas with in vivo tumor transduction with the herpes simplex thymidine kinase gene/ganciclovir system. Hum. Gene Ther. 5:863-890.
40. Ram, Z., K. W. Culver, S. Walbridge, J. A. Frank, R. M. Blaese, and E. H. Oldfield. 1993. Toxicity studies of retroviral-mediated gene transfer for the treatment of brain tumors. J. Neurosurg. 79:400-407.
41. Ram, Z., K. W. Culver, E. Oshiro, J. J. Viola, H. L. DeVroom, E. Otto, Z. Long, Y. Chiang, G. J. McGarrity, L. M. Muul, D. Katz, R. M. Blaese, and E. H. Oldfield. 1997. Therapy of malignant brain tumors by intratumoral implantation of retroviral vector-producing cells. Nat. Med. 12:1354-1361.
42. Reyes, G. R., K.-T. Jeang, and G. S. Hayward. 1982. Transfection with the isolated herpes simplex virus thymidine kinase gene. I. Minimal size of the active fragments from HSV-1 and HSV-2. J. Gen. Virol. 62:191-206.
43. Rizzuto, R., M. Brini, P. Pizzo, M. Murgia, and T. Pozzan. 1995. Chimeric green fluorescent protein as a tool for visualizing subcellular organelles in living cells. Curr. Biol. 5:635-642.
44. Robbins, J., S. Dilworth, R. A. Laskey, and C. Dingwall. 1991. Two interdependent basic domains in nucleoplasmin nuclear targeting sequence: identification of a class of bipartite nuclear targeting sequence. Cell 64:615-623.
45. Roberts, B. L., W. D. Richardson, and A. E. Smith. 1987. The effect of protein context on nuclear localization signal function. Cell 50:465-475.
46. Shiraki, K., T. Ogino, K. Yamanishi, and M. Takahashi. 1985. Immunochemical characterization of pyrimidine kinase induced by varicella-zoster virus. J. Gen. Virol. 66:221-229.
47. Ushinsky, S. C., H. Bussey, A. A. Ahmed, Y. Wang, J. Friesen, B. A. Williams, and R. K. Storms. 1997. Histone H1 in Saccharomyces cerevisiae. Yeast 13: 151-61.
48. Youvan, D. C., and M. E. Michel-Beyerle. 1996. Structure and fluorescence mechanism of GFP. Nat. Biotechnol. 14:1219-1220.